Peptide Quality Should Be Documented, Not Assumed
A peptide labeled “99% pure” does not tell a researcher very much by itself.
What was tested? Which analytical method was used? Was the molecular identity confirmed? Does the report belong to the same lot that was shipped? And what exactly does the purity percentage represent?
At Celtek Peptides, our approach is based on documentation and lot-specific analytical verification.
Research peptides are assigned a lot number, independently analyzed, and accompanied by testing documentation for the material being supplied. Our goal is to make it easier for researchers to understand what they are receiving and the analytical evidence available for that batch.
View Current Test Reports & Certificates
Our Quality Process
Each batch moves through a defined verification and documentation process before it is supplied for research.
1. Lot Identification
Each peptide batch is assigned a lot number.
That lot identifier follows the material through inventory and fulfillment so the analytical documentation can be associated with the specific batch being shipped.
The lot number shown on the product documentation should correspond with the lot received by the researcher.
This is an important distinction. A generic Certificate of Analysis may describe a product, but a lot-specific COA provides information about the actual batch from which the material originated.
2. Independent Analytical Testing
Current Celtek research peptide batches are submitted to independent laboratories for analytical testing.
Routine peptide verification includes:
- HPLC analysis
- mass spectrometry
- lot-specific documentation.
These techniques answer different questions.
HPLC is primarily used to evaluate chromatographic purity.
Mass spectrometry helps confirm that the major analyzed material has a molecular mass consistent with the expected peptide.
Using both methods provides more information than reporting an HPLC purity number alone.
3. Review of Analytical Results
Analytical results are reviewed against the specification for the peptide before the batch is released for sale.
For products represented as 99%+ purity, the chromatographic testing for the current lot should support that specification.
The corresponding analytical report is then made available so researchers can examine the results themselves rather than relying only on a marketing claim.
4. Lot-Specific Documentation
The current testing documentation is associated with the lot being supplied.
Researchers should be able to compare:
Product → Lot Number → Analytical Report
That chain is one of the most useful parts of a peptide quality system because it provides traceability between the material received and the data used to characterize it.
What Does “Peptide Purity” Actually Mean?
Purity is often misunderstood in peptide research.
When a peptide is described as 99% pure, that usually refers to an analytical measurement such as the relative area of the target peak in an HPLC chromatogram.
It does not necessarily mean that 99% of the total physical weight in the vial consists of peptide molecules.
Those are different measurements.
A peptide preparation may also contain components such as:
- water
- counterions
- salts
- residual solvents
- peptide-related impurities.
For this reason, several different concepts should be kept separate:
Chromatographic purity describes the relative amount of the primary peptide peak compared with other detected peaks under the chromatographic conditions used.
Peptide identity asks whether the material corresponds to the intended peptide.
Peptide content describes how much actual peptide is present within the total mass of material.
These measurements can be related, but they are not interchangeable.
HPLC Testing
High-performance liquid chromatography, or HPLC, is one of the standard analytical tools used in peptide characterization.
In reversed-phase HPLC, components in the sample are separated according to how they interact with the chromatography system.
A chromatogram displays peaks corresponding to compounds detected as they leave the column.
The principal peptide normally produces the dominant peak.
Smaller peaks may represent peptide-related impurities or other detectable compounds.
The relative area of the main peak can then be used to estimate chromatographic purity.
For example, a reported result of:
99.2% HPLC purity
generally means that approximately 99.2% of the integrated detected peak area under the stated analytical conditions was attributed to the principal peak.
It does not mean that every possible impurity has been identified or that 99.2% of the physical vial weight is necessarily peptide.
That distinction is important when reading any peptide COA.
Mass Spectrometry
Mass spectrometry provides a different type of information.
Rather than separating compounds according to chromatographic behavior, mass spectrometry measures ions according to their mass-to-charge ratio.
For peptide characterization, the observed mass can be compared with the expected molecular mass of the intended sequence.
A result consistent with the theoretical molecular weight provides evidence supporting peptide identity.
This is why HPLC and mass spectrometry complement one another.
HPLC can show that the sample has a dominant chromatographic component.
Mass spectrometry can help determine whether that component is consistent with the expected peptide.
Neither method should simply be substituted for the other.
Purity Is Not the Same as Identity
A highly pure sample can still theoretically be the wrong molecule.
Imagine an HPLC chromatogram containing one dominant peak representing 99% of detected peak area.
That tells us the sample is chromatographically very clean.
But HPLC purity alone does not prove that the dominant peak is the intended peptide sequence.
Identity needs separate analytical support.
This is why Celtek uses both chromatographic and mass-spectrometric information when characterizing research peptides.
Researchers interested in this distinction can read our full guide:
Peptide Identity vs. Purity: Why They Are Not the Same Thing
What a Certificate of Analysis Should Tell You
A useful peptide Certificate of Analysis should make it possible to connect the analytical result to the material being supplied.
Depending on the product and report, useful information may include:
- compound or peptide name
- lot or batch number
- analytical method
- HPLC chromatogram
- chromatographic purity
- mass spectrometry result
- expected molecular mass
- observed molecular mass
- test date
- laboratory information where applicable.
The key idea is traceability.
A test report is much more useful when the researcher can determine which batch was tested and whether that is the same batch represented by the material in hand.
Lot Traceability
Lot numbers are more than inventory labels.
They create a connection between:
the physical material, analytical testing, inventory records, and shipping documentation.
This becomes especially important when multiple batches of the same peptide exist over time.
Suppose a peptide was tested at 99.4% purity in January and a new production batch arrived in June.
The January COA should not automatically be treated as evidence for the June batch.
The new batch needs its own applicable documentation.
Celtek’s goal is to maintain lot-specific records so the testing displayed for a product corresponds to the batch currently being distributed.
Current Test Reports
The most recent analytical reports for currently supplied batches should be made available through the Celtek testing and Certificate of Analysis library.
When reviewing a report, researchers should check the lot number rather than looking only at the peptide name.
This helps confirm that the report corresponds to the material being evaluated.
View Test Reports & Certificates
What HPLC and Mass Spectrometry Do Not Prove
Good quality documentation also requires being clear about the limits of a test.
Routine HPLC and mass-spectrometry results should not automatically be interpreted as proof of:
- sterility
- absence of bacterial endotoxin
- absence of every possible contaminant
- suitability for injection
- pharmaceutical-grade manufacturing
- safety in humans or animals
- therapeutic effectiveness.
Those are separate questions that require different testing, manufacturing standards, or regulatory evaluation.
This is particularly important for research-use-only peptides.
A clean HPLC chromatogram and an expected molecular mass can provide useful analytical evidence about purity and identity. They do not convert a research chemical into an approved pharmaceutical product.
What Does “Third-Party Tested” Mean?
For Celtek products, third-party testing means analytical testing is performed by an independent laboratory rather than relying solely on a supplier’s internal representation of the material.
There is value in that separation.
An outside laboratory can provide independent analytical data that can then be reviewed alongside the product specification.
But “third-party tested” should still not be treated as a blanket quality claim.
Researchers should look at:
- what was tested
- which method was used
- which lot was tested
- when it was tested
- what the result actually says.
The analytical report matters more than the phrase itself.
Why Analytical Method Matters
A percentage without a method is difficult to interpret.
Consider these statements:
99% pure
and:
99.1% chromatographic purity by RP-HPLC, with molecular identity supported by mass spectrometry.
The second statement tells the researcher much more.
It identifies:
- the type of measurement
- the analytical basis
- the result
- and the separate identity test.
Celtek’s quality approach is intended to emphasize that kind of documented information rather than relying on unsupported purity language.
Research Peptides Are Not Pharmaceutical Products
Celtek Peptides supplies materials for in-vitro laboratory research and development use only.
Research peptide analytical testing should not be confused with pharmaceutical release testing.
Pharmaceutical products intended for human administration operate under a much broader system of manufacturing controls, specifications, validation, microbiological requirements, stability programs, and regulatory oversight.
A research peptide COA showing HPLC and mass-spectrometry results does not establish that the material is:
- FDA approved
- sterile
- injectable
- suitable for human use
- suitable for veterinary use.
Celtek research products are not supplied for those purposes.
Storage and Handling Matter After Testing
Analytical quality at the time of testing is only one part of peptide handling.
Peptides can degrade over time through pathways such as:
- oxidation
- deamidation
- hydrolysis
- aggregation
- isomerization.
Temperature, moisture, light, oxygen exposure, sequence composition, and physical form can all influence peptide stability.
For that reason, researchers should follow the storage information provided for the specific material and minimize unnecessary environmental exposure.
A peptide that was analytically characterized when released can still change if stored improperly.
Quality Standards for Custom Peptide Synthesis
Custom peptide projects may involve additional specifications depending on the research requirements.
These can include:
- requested purity
- peptide quantity
- sequence length
- modifications
- HPLC purification
- HPLC analytical testing
- mass spectrometry
- additional analytical services where requested.
Custom peptide projects are evaluated individually because the appropriate specification depends on the sequence and intended research application.
Researchers can learn more on our:
Custom Peptide Synthesis page.
How to Evaluate a Peptide COA
When reviewing any peptide Certificate of Analysis, not just one from Celtek, ask a few simple questions.
Does the COA identify the batch?
Look for a lot or batch number.
Does that lot match the material?
A test for another production batch is less useful.
Is the analytical method stated?
A purity number should identify how purity was measured.
Is identity tested separately?
HPLC purity alone does not prove molecular identity.
Can you see the underlying analytical data?
A chromatogram and mass spectrum provide more useful information than a certificate containing only a typed percentage.
Are claims limited to what was actually tested?
Do not interpret HPLC/MS results as microbiological, toxicological, or clinical testing.
These questions make it much easier to distinguish meaningful analytical documentation from a generic “99% purity” claim.
Frequently Asked Questions
Are Celtek peptides third-party tested?
Current Celtek research peptide batches are independently analyzed, with analytical documentation associated with the applicable lot.
What testing is used?
Routine characterization includes HPLC analysis for chromatographic purity and mass spectrometry to support peptide identity.
What does 99% peptide purity mean?
In most peptide testing contexts, the percentage refers to chromatographic purity measured by a method such as HPLC. It should not automatically be interpreted as peptide content by physical weight.
Does HPLC prove peptide identity?
No. HPLC primarily provides chromatographic separation and purity information. Mass spectrometry provides additional evidence regarding molecular identity.
Does mass spectrometry measure purity?
Not in the same way as an HPLC purity calculation. The two methods provide different analytical information.
Does a COA mean a peptide is sterile?
No. HPLC and routine mass spectrometry do not establish sterility.
Does testing make a research peptide safe for human use?
No. Analytical characterization of a research peptide does not establish safety, clinical effectiveness, pharmaceutical manufacturing status, or regulatory approval.
How do I find the COA for my peptide?
Use the peptide name and lot number to locate the corresponding report in Celtek’s Test Reports and Certificates section.
View Current Testing Documentation
Quality claims are most useful when researchers can examine the supporting data.
Browse current Celtek Certificates of Analysis and analytical reports by peptide and lot number.
View Test Reports & Certificates
For questions about analytical results, custom specifications, or peptide synthesis requirements, contact Celtek Peptides.
For Research Use Only. Not for human or veterinary use. Not for diagnostic or therapeutic use.